The digital health company plans to raise around $230 million and offer 10.7 million shares. This could potentially double Livongo Health’s valuation, which was set at $1 billion in March.
Livongo Health has hired JPMorgan Chase, Morgan Staley and Goldman Sacks Group to serve as underwriters to assist with the IPO. The company has already privately raised around $240 million. By 2020, Livongo Health plans to double its revenue, sources familiar with the company confirmed to The Wall Street Journal.
More articles about health IT:
Physician viewpoint: 5 traits successful physician-innovators have in common
2019 health IT funding reaches all-time high, report finds: 4 notes
Google’s 5 latest health-related job openings
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
